azacitidine,quizartinib,venetoclax
abbvie,roche,daiichi sankyo
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'ven-a-qui', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax', 'aza ']
updated results of ven-a-qui study: a ph 1-2 trial to assess the safety and efficacy of triplets for nd unfit aml patients: aza or l-d arac with venetoclax and quirzatinib by dr juan miguel bergua #aml #eha2023 
MD, PhD. Hematologist in CHUAC (A Coruña-Spain). Leukemia,Bone Marrow Transplantation and CAR-T. Tweets and opinions are mine.